ReviewMaterials (Basel, Switzerland)2026
Stimuli-Responsive Carriers for Delivery of Anticancer Bioactive Agents.
Review in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The review describes advances in stimulus-sensitive carriers for chemotherapy of various organs, since selectivity in cytotoxicity against cancer and normal cells is a key factor in effective cancer treatment. Special attention is devoted to particle carriers composed of natural compounds, such as lipids, phospholipids, oligopeptides, and synthetic macromolecules, that are sensitive to internal or external stimuli, and delivered to targeted body tissue in a controlled manner. The stimuli discussed include the following: temperature, pH, enzymes, electromagnetic radiation, ultrasound, and redox potential. The description of stimulus-sensitive drug delivery, the methods for synthesizing polymers and copolymers, and the preparation of nano- and microparticles are briefly presented. A description of drug delivery systems (DDSs) with controlled release to specific organs, such as the breast, intestine, lung, prostate, etc., is preceded by a description of methods for preparing drug carriers. The review also covers DDSs at various stages of preclinical and clinical trials and summarizes the state of knowledge on this subject.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.